Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 151, Issue -, Pages 113116
Publisher
Elsevier BV
Online
2022-05-19
DOI
10.1016/j.biopha.2022.113116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Entrectinib, a new multi-target inhibitor for cancer therapy
- (2022) Qinghua Jiang et al. BIOMEDICINE & PHARMACOTHERAPY
- Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy
- (2021) Xiao-Jing Pang et al. MOLECULES
- Focal adhesion kinase inhibitors in the treatment of solid tumors: Preclinical and clinical evidence
- (2021) Patricia A. Quispe et al. DRUG DISCOVERY TODAY
- A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles
- (2021) Muhamad Mustafa et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights
- (2021) Mostafa M. Elbadawi et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
- (2021) Ilaria Romito et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials
- (2020) Atish Mohanty et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer
- (2020) Peng Song et al. Thoracic Cancer
- Design and screening of FAK, CDK 4/6 dual inhibitors by pharmacophore model, molecular docking, and molecular dynamics simulation
- (2020) Chuance Sun et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Chemically Induced Degradation of FAK-ALK for Application in Cancer Therapeutics
- (2020) Robert B. Kargbo ACS Medicinal Chemistry Letters
- Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)
- (2020) Jie Chen et al. Acta Pharmaceutica Sinica B
- Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
- (2020) Flávia Alves Verza et al. Cancers
- Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors
- (2020) Amr K.A. Bass et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK)
- (2020) Yang Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bifunctional HDAC Therapeutics: One Drug to Rule Them All?
- (2020) Joshua P. Smalley et al. MOLECULES
- A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition
- (2020) Qiu-Yun Luo et al. BIOCHEMICAL PHARMACOLOGY
- Pharmacological inhibition of focal adhesion kinase 1 (FAK1) and anaplastic lymphoma kinase (ALK) identified via kinome profile analysis attenuates lipopolysaccharide-induced endothelial inflammatory activation
- (2020) Erna-Zulaikha Dayang et al. BIOMEDICINE & PHARMACOTHERAPY
- Glutathione-triggered non-template synthesized porous carbon nanospheres serve as low toxicity targeted delivery system for cancer multi-therapy
- (2020) Haoyuan Lv et al. CHINESE CHEMICAL LETTERS
- A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours
- (2019) Gabriel Mak et al. BRITISH JOURNAL OF CANCER
- FAK and Pyk2 activity promote TNF-α and IL-1β-mediated pro-inflammatory gene expression and vascular inflammation
- (2019) James M. Murphy et al. Scientific Reports
- FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
- (2019) Carlos J Diaz Osterman et al. eLife
- Design and synthesis of diphenylpyrimidine derivatives (DPPYs) as potential dual EGFR T790M and FAK inhibitors against a diverse range of cancer cell lines
- (2019) Min Ai et al. BIOORGANIC CHEMISTRY
- TAE226, a dual inhibitor of focal adhesion kinase and insulin‐like growth factor‐I receptor, is effective for Ewing sarcoma
- (2019) Hiroshi Moritake et al. Cancer Medicine
- Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer
- (2019) David E. Gerber et al. LUNG CANCER
- The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells
- (2018) Nicole Kiweler et al. ARCHIVES OF TOXICOLOGY
- Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma
- (2018) Rajani Kanteti et al. CANCER BIOLOGY & THERAPY
- Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R–YAP Axis
- (2018) Hong Zhu et al. CANCER RESEARCH
- Identification of highly potent BTK and JAK3 dual inhibitors with improved activity for the treatment of B-cell lymphoma
- (2018) Yang Ge et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells
- (2018) Rania S.M. Ismail et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- An UPLC–MS/MS method to determine CT-707 and its two metabolites in plasma of ALK-positive advanced non-small cell lung cancer patients
- (2018) Cheng Cui et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- A role for focal adhesion kinase in facilitating the contractile responses of murine gastric fundus smooth muscles
- (2018) Yeming Xie et al. JOURNAL OF PHYSIOLOGY-LONDON
- A Study of the Focal Adhesion Kinase Inhibitor GSK2256098 in Patients with Recurrent Glioblastoma with Evaluation of Tumor Penetration of [11C]GSK2256098
- (2018) Nicholas F Brown et al. NEURO-ONCOLOGY
- Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer
- (2018) Hui-Ming Lin et al. PROSTATE
- Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development
- (2018) Rayan Naser et al. Cancers
- HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors
- (2018) Rekha Sangwan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting EGFRL858R/T790M and EGFRL858R/T790M/C797S resistance mutations in NSCLC: Current developments in medicinal chemistry
- (2018) Xiaoyun Lu et al. MEDICINAL RESEARCH REVIEWS
- The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer
- (2018) Stefanie Tiede et al. Oncogenesis
- CT-707 Overcomes Resistance of crizotinib through activating PDPK1-AKT1 pathway by targeting FAK
- (2018) Caixia Liang et al. CURRENT CANCER DRUG TARGETS
- FAK and S6K1 Inhibitor, Neferine, Dually Induces Autophagy and Apoptosis in Human Neuroblastoma Cells
- (2018) Dinh-Chuong Pham et al. MOLECULES
- VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters
- (2018) Ning Ji et al. Frontiers in Pharmacology
- Synthesis and biological evaluation of morpholine-substituted diphenylpyrimidine derivatives (Mor-DPPYs) as potent EGFR T790M inhibitors with improved activity toward the gefitinib-resistant non-small cell lung cancers (NSCLC)
- (2017) Zhendong Song et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Designing multi-targeted agents: An emerging anticancer drug discovery paradigm
- (2017) Rong-geng Fu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy
- (2017) B Xu et al. Oncogenesis
- A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors
- (2016) J. C. Soria et al. ANNALS OF ONCOLOGY
- Identification of novel FAK and S6K1 dual inhibitors from natural compounds via ADMET screening and molecular docking
- (2016) Varadharajan Thiyagarajan et al. BIOMEDICINE & PHARMACOTHERAPY
- HDAC2 promotes the migration and invasion of non-small cell lung cancer cells via upregulation of fibronectin
- (2016) Li Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Synthesis and biological evaluation of azole-diphenylpyrimidine derivatives (AzDPPYs) as potent T790M mutant form of epidermal growth factor receptor inhibitors
- (2016) Zhendong Song et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency
- (2016) Julie Farand et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors
- (2016) Toshio Shimizu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Discovery of novel dual inhibitors of VEGFR and PI3K kinases containing 2-ureidothiazole scaffold
- (2016) Lin Li et al. CHINESE CHEMICAL LETTERS
- Focal Adhesion Kinase Regulates the DNA Damage Response and Its Inhibition Radiosensitizes Mutant KRAS Lung Cancer
- (2016) K.-J. Tang et al. CLINICAL CANCER RESEARCH
- Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer
- (2016) H. D. Skinner et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Endothelial Cell FAK--A Target for Cancer Treatment
- (2016) M. Roy-Luzarraga et al. CLINICAL CANCER RESEARCH
- Challenges and Perspectives on the Development of Small-Molecule EGFR Inhibitors against T790M-Mediated Resistance in Non-Small-Cell Lung Cancer
- (2016) Zhendong Song et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK)
- (2016) Gregory R. Ott et al. JOURNAL OF MEDICINAL CHEMISTRY
- CT-707, a Novel FAK Inhibitor, Synergizes with Cabozantinib to Suppress Hepatocellular Carcinoma by Blocking Cabozantinib-Induced FAK Activation
- (2016) Dan-Dan Wang et al. MOLECULAR CANCER THERAPEUTICS
- Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
- (2016) Hong Jiang et al. NATURE MEDICINE
- Initial testing of VS-4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program
- (2016) Raushan T. Kurmasheva et al. PEDIATRIC BLOOD & CANCER
- Myelodysplastic syndromes: Contemporary review and how we treat
- (2015) Naseema Gangat et al. AMERICAN JOURNAL OF HEMATOLOGY
- Designed to Kill: Novel Menin-MLL Inhibitors Target MLL -Rearranged Leukemia
- (2015) Michael W.M. Kühn et al. CANCER CELL
- Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
- (2015) Alan Serrels et al. CELL
- Targeting FAK scaffold functions inhibits human renal cell carcinoma growth
- (2015) Claire Béraud et al. INTERNATIONAL JOURNAL OF CANCER
- A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
- (2015) Suzanne F. Jones et al. INVESTIGATIONAL NEW DRUGS
- Novel ALK inhibitors in clinical use and development
- (2015) Chaitanya Iragavarapu et al. Journal of Hematology & Oncology
- Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms
- (2015) Diarmaid Hughes et al. NATURE REVIEWS GENETICS
- HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population
- (2015) SER YENG LER et al. ONCOLOGY REPORTS
- Current status and progress of pancreatic cancer in China
- (2015) Quan-Jun Lin WORLD JOURNAL OF GASTROENTEROLOGY
- Emerging Roles of Focal Adhesion Kinase in Cancer
- (2015) Yu-Ling Tai et al. Biomed Research International
- ALK inhibitors in non-small cell lung cancer: the latest evidence and developments
- (2015) Ivana Sullivan et al. Therapeutic Advances in Medical Oncology
- The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth
- (2015) Elena Kurenova et al. Oncotarget
- PND-1186 FAK inhibitor selectively promotes tumore cell apoptosis in three-dimensional environments
- (2014) Michael D. Schaller et al. CANCER BIOLOGY & THERAPY
- A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells
- (2014) Elena Kurenova et al. CELL CYCLE
- Pharmacokinetic analysis of the FAK scaffold inhibitor C4 in dogs
- (2014) John Wilton et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Design, synthesis, and biological evaluation of novel FAK scaffold inhibitors targeting the FAK–VEGFR3 protein–protein interaction
- (2014) Priyanka N. Gogate et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
- (2014) Kunal Nepali et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review
- (2014) Ekambaram Shanthi et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Targeting FAK in human cancer: from finding to first clinical trials
- (2014) Vita Golubovskaya Frontiers in Bioscience-Landmark
- Understanding the Roles of FAK in Cancer
- (2014) Hyunho Yoon et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Mitoxantrone Targets the ATP-binding Site of FAK, Binds the FAK Kinase Domain and Decreases FAK, Pyk-2, c-Src, and IGF-1R In Vitro Kinase Activities
- (2013) Vita M. Golubovskaya et al. Anti-Cancer Agents in Medicinal Chemistry
- High-Throughput Tyrosine Kinase Activity Profiling Identifies FAK as a Candidate Therapeutic Target in Ewing Sarcoma
- (2013) B. D. Crompton et al. CANCER RESEARCH
- Fragment-Based Discovery of New Highly Substituted 1H-Pyrrolo[2,3-b]- and 3H-Imidazolo[4,5-b]-Pyridines as Focal Adhesion Kinase Inhibitors
- (2013) Timo Heinrich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of Focal Adhesion Kinase in Regulating YB–1–Mediated Paclitaxel Resistance in Ovarian Cancer
- (2013) Yu Kang et al. JNCI-Journal of the National Cancer Institute
- Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma
- (2013) Jerry E. Stewart et al. MOLECULAR CARCINOGENESIS
- RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas
- (2013) Georgia Konstantinidou et al. Cancer Discovery
- Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
- (2012) James S. Duncan et al. CELL
- Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth
- (2012) Deniz A. Ucar et al. CELL CYCLE
- Safety, Pharmacokinetic, and Pharmacodynamic Phase I Dose-Escalation Trial of PF-00562271, an Inhibitor of Focal Adhesion Kinase, in Advanced Solid Tumors
- (2012) Jeffrey R. Infante et al. JOURNAL OF CLINICAL ONCOLOGY
- TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer
- (2012) M K Wendt et al. ONCOGENE
- Overexpression of S6 Kinase 1 in Brain Tumours Is Associated with Induction of Hypoxia-Responsive Genes and Predicts Patients' Survival
- (2012) Heba M.S. Ismail Journal of Oncology
- Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
- (2011) Brian Magnuson et al. BIOCHEMICAL JOURNAL
- Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases
- (2011) Craig A. Zificsak et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- JAK inhibitors in myeloproliferative neoplasms: Rationale, current data and perspective
- (2011) A. Tefferi et al. BLOOD REVIEWS
- Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo
- (2011) Elena V. Kurenova et al. CELL CYCLE
- Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo
- (2011) Naito Kurio et al. EXPERIMENTAL CELL RESEARCH
- Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease
- (2011) Rafael León et al. MEDICINAL RESEARCH REVIEWS
- Inhibition of Focal Adhesion Kinase by PF-562,271 Inhibits the Growth and Metastasis of Pancreatic Cancer Concomitant with Altering the Tumor Microenvironment
- (2011) J. B. Stokes et al. MOLECULAR CANCER THERAPEUTICS
- Aberrant Regulation of HDAC2 Mediates Proliferation of Hepatocellular Carcinoma Cells by Deregulating Expression of G1/S Cell Cycle Proteins
- (2011) Ji Heon Noh et al. PLoS One
- Histone Deacetylase (HDAC) 1 and 2 Expression and Chemotherapy in Gastric Cancer
- (2010) Kathrin Mutze et al. ANNALS OF SURGICAL ONCOLOGY
- Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer
- (2010) Gizeh Pérez-Tenorio et al. BREAST CANCER RESEARCH AND TREATMENT
- Sunitinib and PF-562,271 (FAK/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft model
- (2010) Cedo M Bagi et al. CANCER BIOLOGY & THERAPY
- PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments
- (2010) Isabelle Tanjoni et al. CANCER BIOLOGY & THERAPY
- Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models
- (2010) Colin Walsh et al. CANCER BIOLOGY & THERAPY
- Dynamic interactions between cells and their extracellular matrix mediate embryonic development
- (2010) Michelle F. Goody et al. MOLECULAR REPRODUCTION AND DEVELOPMENT
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Proline-rich tyrosine kinase-2 is critical for CD8 T-cell short-lived effector fate
- (2010) S. Beinke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
- (2009) Paul D. W. Eckford et al. CHEMICAL REVIEWS
- STAT3 as a Central Regulator of Tumor Metastases
- (2009) Eswaran Devarajan et al. CURRENT MOLECULAR MEDICINE
- TAE226-mediated inhibition of focal adhesion kinase interferes with tumor angiogenesis and vasculogenesis
- (2009) Alexander Schultze et al. INVESTIGATIONAL NEW DRUGS
- Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design
- (2009) Seungil Han et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small Molecule Chloropyramine Hydrochloride (C4) Targets the Binding Site of Focal Adhesion Kinase and Vascular Endothelial Growth Factor Receptor 3 and Suppresses Breast Cancer Growth in Vivo
- (2009) Elena V. Kurenova et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
- (2009) Wenjun Zhou et al. NATURE
- Transport proteins of the ABC family and multidrug resistance of tumor cells
- (2008) A. A. Stavrovskaya et al. BIOCHEMISTRY-MOSCOW
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- TAE226 Inhibits Human Neuroblastoma Cell Survival
- (2008) Elizabeth A. Beierle et al. CANCER INVESTIGATION
- Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271
- (2008) W. G. Roberts et al. CANCER RESEARCH
- S6 Kinase 1 Regulates Estrogen Receptor α in Control of Breast Cancer Cell Proliferation
- (2008) Rachel L. Yamnik et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK
- (2008) Sara M. Weis et al. JOURNAL OF CELL BIOLOGY
- Nuclear FAK Promotes Cell Proliferation and Survival through FERM-Enhanced p53 Degradation
- (2008) Ssang-Taek Lim et al. MOLECULAR CELL
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started